JP2013530931A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530931A5
JP2013530931A5 JP2013505286A JP2013505286A JP2013530931A5 JP 2013530931 A5 JP2013530931 A5 JP 2013530931A5 JP 2013505286 A JP2013505286 A JP 2013505286A JP 2013505286 A JP2013505286 A JP 2013505286A JP 2013530931 A5 JP2013530931 A5 JP 2013530931A5
Authority
JP
Japan
Prior art keywords
dosage form
poly
active ingredient
biologically active
form according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013505286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530931A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2011/000447 external-priority patent/WO2011130834A1/en
Publication of JP2013530931A publication Critical patent/JP2013530931A/ja
Publication of JP2013530931A5 publication Critical patent/JP2013530931A5/ja
Pending legal-status Critical Current

Links

JP2013505286A 2010-04-23 2011-04-21 液状生物学的活性成分の固形製剤を含む非静脈内剤型およびその使用 Pending JP2013530931A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32734810P 2010-04-23 2010-04-23
US61/327,348 2010-04-23
PCT/CA2011/000447 WO2011130834A1 (en) 2010-04-23 2011-04-21 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017094186A Division JP6572256B2 (ja) 2010-04-23 2017-05-10 液状生物学的活性成分の固形製剤を含む非静脈内剤型およびその使用

Publications (2)

Publication Number Publication Date
JP2013530931A JP2013530931A (ja) 2013-08-01
JP2013530931A5 true JP2013530931A5 (cg-RX-API-DMAC7.html) 2014-05-29

Family

ID=44833585

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013505286A Pending JP2013530931A (ja) 2010-04-23 2011-04-21 液状生物学的活性成分の固形製剤を含む非静脈内剤型およびその使用
JP2017094186A Active JP6572256B2 (ja) 2010-04-23 2017-05-10 液状生物学的活性成分の固形製剤を含む非静脈内剤型およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017094186A Active JP6572256B2 (ja) 2010-04-23 2017-05-10 液状生物学的活性成分の固形製剤を含む非静脈内剤型およびその使用

Country Status (6)

Country Link
US (1) US20130039864A1 (cg-RX-API-DMAC7.html)
EP (1) EP2563349A4 (cg-RX-API-DMAC7.html)
JP (2) JP2013530931A (cg-RX-API-DMAC7.html)
CA (1) CA2797098C (cg-RX-API-DMAC7.html)
IL (1) IL222568A (cg-RX-API-DMAC7.html)
WO (1) WO2011130834A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
EP2563349A4 (en) * 2010-04-23 2014-03-19 Paladin Labs Inc Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof
US11331271B2 (en) * 2016-05-27 2022-05-17 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol
JP6912876B2 (ja) * 2016-10-06 2021-08-04 三洋化成工業株式会社 アクリル系医薬固形製剤用添加剤
GB2561009B (en) * 2017-03-31 2020-05-13 Altus Formulation Inc Non-ionic PVP-PLA block copolymers and pharmaceutical compositions derived therefrom
WO2021247463A1 (en) * 2020-06-02 2021-12-09 Purdue Research Foundation Formulation of monodisperse kinetically frozen polymer micelles via equilibration-nanoprecipitation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1120109A3 (en) * 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
US6338859B1 (en) * 2000-06-29 2002-01-15 Labopharm Inc. Polymeric micelle compositions
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
PT1558935E (pt) * 2002-10-25 2008-10-16 Labopharm Inc Composições de libertação controlada
AU2004259209A1 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
WO2005058250A2 (en) * 2003-12-17 2005-06-30 Mgi Gp, Inc. Methods of administering water-soluble prodrugs of propofol for extended sedation
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
MX2009003092A (es) * 2006-09-22 2009-05-08 Labopharm Inc Composiciones y metodos para suministro de farmaco dirigido a ph.
EP2164475A2 (en) * 2007-07-16 2010-03-24 NorthEastern University Therapeutic stable nanoparticles
HRP20191104T1 (hr) * 2007-09-25 2019-09-20 Solubest Ltd. Pripravci koji sadrže lipofilne aktivne spojeve i postupak za njihovu pripremu
FR2930444B1 (fr) * 2008-04-29 2010-06-04 Servier Lab Micelles polymerisees
EP2563349A4 (en) * 2010-04-23 2014-03-19 Paladin Labs Inc Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof

Similar Documents

Publication Publication Date Title
JP7038741B2 (ja) 放出制御が容易な徐放性薬物微粒子の製造方法
US9980902B2 (en) Method for treating intestinal fibrosis
CN105832678A (zh) 生物利用度提高的包含难溶性药物的微球及其制备方法
HRP20161154T1 (hr) Farmaceutska formulacija 514
JP2009155282A (ja) 固体分散体含有医薬組成物
JP2015522001A5 (cg-RX-API-DMAC7.html)
WO2014108076A1 (zh) 难溶性药物凝胶组合物及其制备方法
TW200821298A (en) Pharmaceutical compositions
KR20160093611A (ko) 경구 투여를 위한 약물 제제의 제조 방법
JP2013103899A (ja) 難溶性薬物の新規な固体分散体
CN105708819A (zh) 医药制剂
JP2017505822A5 (cg-RX-API-DMAC7.html)
Vadlamudi et al. Significance of excipients to enhance the bioavailability of poorly water-soluble drugs in oral solid dosage forms: A Review
Zhang et al. Study on the effect of polymer excipients on the dispersibility, interaction, solubility, and scavenging reactive oxygen species of myricetin solid dispersion: experiment and molecular simulation
KR20090130325A (ko) 약학 부형제 복합체
JP2019514993A (ja) 改善された薬物製剤
CN105120899A (zh) 选择性孕激素受体调节剂的固体分散体
TW201110968A (en) A thrombin receptor antagonist and clopidogrel fixed dose tablet
US20240100165A1 (en) Solid snedds based on a specific mixture of acrylic polymers
JP2012500788A5 (cg-RX-API-DMAC7.html)
JP2022177014A (ja) Hcvを処置するための固体医薬組成物
CN115697305A (zh) 固体自纳米乳化药物递送系统(s-snedds)
JP2018123140A (ja) 活性成分(i)含有組成物及びその製造方法
CN107427462A (zh) 固态分散体
CA3188796A1 (en) Thromboxane receptor antagonist formulations